Raising Questions or Concerns
Suppliers must report ethics and compliance concerns that might affect Boehringer Ingelheim. Click here to read and find out more information.
Search
MORE GREEN: Environmental sustainability at a glance
On Earth Day, we share the progress of our global environmental sustainability MORE GREEN program and what the team is tackling, all 365 days of the year.
Patient voices Ulrichs story
‘Telling My Story’ is a video series featuring stories from patients from across the world with AF, DVT and PE. Click here to hear Ulrich's story.
Patient voices Eves story
‘Telling My Story’ is a video series featuring stories from patients from across the world with AF, DVT and PE. Click here to hear Eve's story.
Patient voices Augustos story
Hear from patients and families on how atrial fibrillation (AF), deep vein thrombosis (DVT) and pulmonary embolism (PE) have affected their lives.
COVID-19
COVID-19
From Idea to Drug
Development of a new drug starts with the hunt for effective compounds and finishes with the approval of the drug. Click here to learn more.
My.Making More Health Website
My.Making More Health, our platform for disadvantaged communities goes live, providing materials on health prevention for all. Click here to learn more.
New approaches in the battle against heartworm disease
Heartworm disease is a concern to dog and cat owners worldwide. Current disease control methods are increasingly challenged by drug resistance. Read more.
1988-2015
Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.
Spotlight on poultry chicken trends
What’s going on in regional poultry markets around the globe? We asked some of our customers! Click here to find out what they had to say and more.
COVID-19 Q&A for people with diabetes
Here you can find a summary of COVID-19 advice for patients with diabetes. Click here to read the questions and answers to find out more information.
Professor Baumgart
After being diagnosed with diabetes, Eric’s unique bonds with Peetey and Jake meant they could run miles across the Idaho wilderness. Learn more here.
Solidarity with Ukraine
Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term. Click here to learn more.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
Our Employees
We offer our employees demanding and challenging tasks. Boehringer Ingelheim needs employees who innovate. Learn more about our employees here.
fighting pet parasites with holistic approach france
When animals are healthy, humans are healthier, too. This is especially true for parasitic diseases that affect our pets to whom we are close. Read more.
1948-1988
Following the death of Albert Boehringer (1861-1939), his two sons and his son-in-law Julius Liebrecht took over this family company. Learn more.
Stroke
Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Ethical Business Practices
Suppliers shall conduct their business in an ethical manner and act with integrity. Click here to read the supplier code of conduct and learn more.
Data Privacy
Boehringer Ingelheim International GmbH takes the protection of your personal data seriously. Click here to find out more about data privacy.
Imprint
Here you can access contact details and information about Boehringer Ingelheim International GmbH. Click here to find out and learn more information.
This ensures food security for one year
In Ghana, we are helping smallholder farmers overcome hardship caused by the pandemic. Click here to read about this story and find out more.
COVID-19 France Production of hydroalcoholic-gel
We have launched production of our first hydro-alcoholic solution for internal use to help battle COVID-19. Click here to find out and learn more.
Supporting Fundappas
Fundappas is the first school of guide and assistance dogs in Uruguay. We support Fundappas to improve the quality of life of dogs and people. Learn more.